ESSEX INVESTMENT MANAGEMENT CO LLC
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 201772
BOSTON, MA
Position in SNDX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,648,289
New position
Shares Held
198,985
first reported quarter
Ownership
0.223%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 66%
Shared 0%
None 34%
Position in Biotechnology
Healthcare · as of Jun 30, 2026ESSEX INVESTMENT MANAGEMENT CO LLC holds $67,663,995 across 13 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
43,567 | $13,771,093 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
105,669 | $12,370,669 | |
| 3 | TVTX |
Travere Therapeutics, Inc.
|
133,866 | $7,604,927 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
21,665 | $5,220,615 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
482,154 | $4,734,752 | |
| 6 | INSM |
INSMED Inc
|
42,991 | $4,583,700 | |
| 7 | PGEN |
Precigen, Inc.
|
706,294 | $4,025,875 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
16,244 | $3,976,043 |
All Filings in SNDX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,648,289 | 198,985 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||